Celestone Soluspan Injection, Suspension
Product Images NDC 78206-118

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Celestone Soluspan (NDC 78206-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Betamethasone Sodium Phosphate And Betamethasone Acetate Chemical Structures (Celestone Soluspan 01)

Chemical structure diagrams of betamethasone sodium phosphate and betamethasone acetate, showing the molecular configurations of the two active ingredients in CELESTONE SOLUSPAN injection suspension.*

FDA Label Image

Principal Display Panel (5 mL Vial Box)

The packaging label for Celestone Soluspan injection, suspension, USP contains 30 mg per 5 mL (6 mg/mL) of betamethasone sodium phosphate and betamethasone acetate. The label indicates it is a 5 mL multiple-dose vial for intramuscular, intra-articular, soft tissue, intralesional, intrabursal, and intradermal use. Manufactured by Organon LLC, the label instructs to shake well before use and includes storage and dosage details, barcodes, and spaces for SN, Exp, and Lot numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.